At the recent Boston AF Symposium, investigators of the STOP AF clinical trial, which investigated the effectiveness and safety of Medtronic’s Arctic Front Cardiac CryoAblation Catheter system, showed that electrophysiologists who are more experienced with the device had better success rates and no major complications compared to those who had performed just one or two procedures.
Learn more: Learning Curve Affects Cryoballoon Ablation Success in Treatment of Paroxysmal Atrial Fibrillation